- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
TransMedics Group Inc (TMDX)
TransMedics Group Inc stock price live, this page displays NASDAQ TMDX stock exchange data. View the TMDX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the TransMedics Group Inc real time stock price chart below.
What Is the TransMedics Group Inc Stock Price Today?
The TransMedics Group Inc stock price today is 115.18.
What Is the Stock Symbol for TransMedics Group Inc?
The stock symbol for TransMedics Group Inc is ""TMDX.""
What Stock Exchange Does TransMedics Group Inc Trade On?
TransMedics Group Inc is listed and trades on the NASDAQ stock exchange.
Is TransMedics Group Inc a Good Stock to Buy?
Determining whether TransMedics Group Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TMDX quote. (ISIN: US89377M1099)
What Is the TransMedics Group Inc Stock Price Today?
The TransMedics Group Inc stock price today is 115.18.
What Is the Stock Symbol for TransMedics Group Inc?
The stock symbol for TransMedics Group Inc is ""TMDX.""
What Stock Exchange Does TransMedics Group Inc Trade On?
TransMedics Group Inc is listed and trades on the NASDAQ stock exchange.
Is TransMedics Group Inc a Good Stock to Buy?
Determining whether TransMedics Group Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TMDX quote. (ISIN: US89377M1099)
Currency in USD
Fair Value
An estimate of a TransMedics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
113.90
116.65
52 wk Range
55.00
176.32
TMDX Scorecard
Full Analysis
Net income is expected to grow this year
TMDX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a TransMedics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
113.90116.65
52 wk Range
55.00176.32
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
TMDX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a TransMedics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
142.29
Upside
+23.53%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
4 analysts have revised their earnings upwards for the upcoming period
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
TransMedics Group Inc Company Profile
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.
TransMedics Group Inc SWOT Analysis
Organ Tech Pionee | TransMedics leads in organ transplant technology with its Organ Care System, driving a 109% year-over-year revenue increase and strong market position |
Financial Trajectory | Explore TransMedics' fiscal projections, including 2024 revenue guidance of $428-$432 million and ambitious 2028 targets of $1.2 billion revenue |
Market Dynamics | Delve into TransMedics' dominance in the DCD market and its strategic response to emerging competition from Getinge's acquisition of Paragonix |
Innovation Pipeline | Discover TransMedics' plans for next-gen OCS Lung and Heart programs, digital platform updates, and expansion into new organ transplant segments |
TransMedics Group Inc Earnings Call Summary for Q2/2025
- Q2 2025 EPS of $0.92 beat expectations by 104.44%, revenue up 38% YoY to $157.4M
- Stock rose 3.13% post-announcement, with 1.55% gain in aftermarket trading
- Full-year revenue guidance raised to $585-$605M, targeting 35% YoY increase
- U.S. transplant revenue grew 40% YoY; company aims for 30% operating margin by 2028
- Exploring European market expansion; confident in heart and lung clinical trials growth
Last Updated: 31/07/2025, 00:02
Read Full TranscriptCompare TMDX to Peers and Sector
Metrics to compare | TMDX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipTMDXPeersSector | |
|---|---|---|---|---|
P/E Ratio | 54.8x | −3.8x | −0.5x | |
PEG Ratio | 0.03 | −0.28 | 0.00 | |
Price/Book | 12.3x | 2.8x | 2.6x | |
Price / LTM Sales | 7.4x | 2.5x | 3.3x | |
Upside (Analyst Target) | 25.9% | 55.0% | 38.7% | |
Fair Value Upside | Unlock | −0.9% | 5.0% | Unlock |
Analyst Ratings
6 Buy
2 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 142.29
(+23.53% Upside)
Earnings
Latest Release
Jul 30, 2025
EPS / Forecast
0.92 / 0.45
Revenue / Forecast
157.40M / 146.74M
People Also Watch
FAQ
What Stock Exchange Does TransMedics Trade On?
TransMedics is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for TransMedics?
The stock symbol for TransMedics is "TMDX."
What Is the TransMedics Market Cap?
As of today, TransMedics market cap is 3.92B.
What Is TransMedics's Earnings Per Share (TTM)?
The TransMedics EPS (TTM) is 2.13.
When Is the Next TransMedics Earnings Date?
TransMedics will release its next earnings report on 10 Nov 2025.
From a Technical Analysis Perspective, Is TMDX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has TransMedics Stock Split?
TransMedics has split 0 times.
How Many Employees Does TransMedics Have?
TransMedics has 728 employees.
What is the current trading status of TransMedics (TMDX)?
As of 27 Aug 2025, TransMedics (TMDX) is trading at a price of 115.18, with a previous close of 115.18. The stock has fluctuated within a day range of 113.90 to 116.65, while its 52-week range spans from 55.00 to 176.32.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.